Aurora Cannabis Other Share Holders Equity 2017-2024 | ACB
Aurora Cannabis other share holders equity from 2017 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Aurora Cannabis Annual Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $120 |
| 2022 | $124 |
| 2021 | $110 |
| 2020 | $108 |
| 2019 | $105 |
| 2018 | $4 |
| 2017 | $20 |
| 2017 | $ |
| 2016 | $ |
| Aurora Cannabis Quarterly Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-06-30 | $119 |
| 2024-03-31 | $120 |
| 2023-12-31 | $115 |
| 2023-09-30 | $118 |
| 2023-06-30 | $116 |
| 2022-12-31 | $112 |
| 2022-09-30 | $116 |
| 2022-03-31 | $115 |
| 2021-12-31 | $114 |
| 2021-09-30 | $114 |
| 2021-03-31 | $110 |
| 2020-12-31 | $106 |
| 2020-09-30 | $108 |
| 2020-03-31 | $107 |
| 2019-12-31 | $105 |
| 2019-09-30 | $120 |
| 2019-03-31 | $86 |
| 2018-12-31 | $65 |
| 2018-09-30 | $60 |
| 2018-06-30 | |
| 2018-03-31 | $-3 |
| 2017-12-31 | $26 |
| 2017-09-30 | $31 |
| 2017-06-30 | $20 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.328B | $0.200B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
| Stryker (SYK) | United States | $139.868B | 31.52 |
| Boston Scientific (BSX) | United States | $124.863B | 35.90 |
| Medtronic (MDT) | Ireland | $114.537B | 17.04 |
| EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
| ResMed (RMD) | United States | $35.761B | 29.39 |
| Terumo (TRUMY) | Japan | $28.532B | 40.29 |
| Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
| Baxter (BAX) | United States | $18.264B | 12.39 |
| Insulet (PODD) | United States | $16.648B | 70.04 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
| BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
| ICU Medical (ICUI) | United States | $4.201B | 40.09 |
| TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
| Haemonetics (HAE) | United States | $3.763B | 18.61 |
| Envista Holdings (NVST) | United States | $3.662B | 27.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
| Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
| Neogen (NEOG) | United States | $3.127B | 36.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
| QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
| Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
| LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
| Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
| Warby Parker (WRBY) | United States | $1.769B | 0.00 |
| AtriCure (ATRC) | United States | $1.641B | 0.00 |
| InMode (INMD) | Israel | $1.460B | 8.78 |
| AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
| Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
| Evolus (EOLS) | United States | $1.036B | 0.00 |
| Owens & Minor (OMI) | United States | $0.925B | 7.23 |
| National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
| Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
| CeriBell (CBLL) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
| Surmodics (SRDX) | United States | $0.536B | 113.85 |
| Quanterix (QTRX) | United States | $0.532B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.398B | 33.56 |
| Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
| OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Jin Medical (ZJYL) | China | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Cerus (CERS) | United States | $0.290B | 0.00 |
| Biote (BTMD) | United States | $0.280B | 12.93 |
| Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
| Zynex (ZYXI) | United States | $0.255B | 53.33 |
| Omeros (OMER) | United States | $0.246B | 0.00 |
| High Tide (HITI) | Canada | $0.234B | 97.00 |
| MacroGenics (MGNX) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Brainsway (BWAY) | Israel | $0.172B | 206.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
| Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
| Fonar (FONR) | United States | $0.092B | 9.51 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.043B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.87 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |